Intraoperative Use of Microscope-Integrated OCT for Subretinal Gene Therapy

Related

• 

  Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial

  Rishi P. Singh, MD

  Annual Meeting Talks

  2018

• 

  My Practice is Worth WHAT? Equity Acquisition in the Retina World

  Robert L. Avery, MD

  Carl W. Baker, MD, FASRS

  Michael S. Jacobson, MD

  Reginald J. Sanders, MD, FASRS

  Annual Meeting Talks

  2018

• 

  Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial

  Charles C Wykoff, MD, PhD, FASRS

  Annual Meeting Talks

  2021